1. Home
  2. PTHL vs RFL Comparison

PTHL vs RFL Comparison

Compare PTHL & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • RFL
  • Stock Information
  • Founded
  • PTHL 1998
  • RFL 2017
  • Country
  • PTHL China
  • RFL United States
  • Employees
  • PTHL N/A
  • RFL N/A
  • Industry
  • PTHL
  • RFL Real Estate
  • Sector
  • PTHL
  • RFL Finance
  • Exchange
  • PTHL Nasdaq
  • RFL Nasdaq
  • Market Cap
  • PTHL 65.0M
  • RFL 55.3M
  • IPO Year
  • PTHL 2024
  • RFL N/A
  • Fundamental
  • Price
  • PTHL $4.20
  • RFL $1.84
  • Analyst Decision
  • PTHL
  • RFL
  • Analyst Count
  • PTHL 0
  • RFL 0
  • Target Price
  • PTHL N/A
  • RFL N/A
  • AVG Volume (30 Days)
  • PTHL 56.3K
  • RFL 25.8K
  • Earning Date
  • PTHL 02-11-2025
  • RFL 12-27-2024
  • Dividend Yield
  • PTHL N/A
  • RFL N/A
  • EPS Growth
  • PTHL N/A
  • RFL N/A
  • EPS
  • PTHL N/A
  • RFL N/A
  • Revenue
  • PTHL $572,291.00
  • RFL $697,000.00
  • Revenue This Year
  • PTHL N/A
  • RFL N/A
  • Revenue Next Year
  • PTHL N/A
  • RFL N/A
  • P/E Ratio
  • PTHL N/A
  • RFL N/A
  • Revenue Growth
  • PTHL 2.32
  • RFL 151.62
  • 52 Week Low
  • PTHL $3.32
  • RFL $1.29
  • 52 Week High
  • PTHL $6.45
  • RFL $2.50
  • Technical
  • Relative Strength Index (RSI)
  • PTHL N/A
  • RFL 45.87
  • Support Level
  • PTHL N/A
  • RFL $1.74
  • Resistance Level
  • PTHL N/A
  • RFL $1.92
  • Average True Range (ATR)
  • PTHL 0.00
  • RFL 0.09
  • MACD
  • PTHL 0.00
  • RFL -0.00
  • Stochastic Oscillator
  • PTHL 0.00
  • RFL 40.91

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

Share on Social Networks: